One prediction isn't enough — Why CEOs are shifting to wartime planning [Fortune]
MaxCyte, Inc. (MXCT)
Company Research
Source: Fortune
Good morning. The single-point forecast is no longer fit for purpose. Recommended Video Scenario planning has become boardroom shorthand for preparation to deal with the unknowable, my colleague Geoff Colvin writes in a Fortune feature titled “For CEOs, it's time for a wartime mindset.” Colvin argues that it's a practice that is never more vital than in wartime — when a cyberattack, or even a sanction, can reroute supply chains overnight and send energy prices soaring. He writes: “Instead of betting on one forecast about how events will unfold, the most resilient CEOs are now rehearsing several plausible futures at once and deciding — before the missiles start dropping, the virus becomes a pandemic, or the markets seize up — what they will do in each. “It's an approach that was pioneered by Shell precursor Royal Dutch Shell. In the 1970s, the energy company began developing a set of vivid alternative futures involving potential oil-supply disruptions. Shell did not invent t
Show less
Read more
Impact Snapshot
Event Time:
MXCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MXCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MXCT alerts
High impacting MaxCyte, Inc. news events
Weekly update
A roundup of the hottest topics
MXCT
News
- MaxCyte (MXCT) had its price target lowered by Craig Hallum from $7.00 to $5.00. They now have a "buy" rating on the stock.MarketBeat
- MaxCyte outlines $30M–$32M 2026 revenue target as ExPERT DTx launch and SPL milestones drive outlook [Seeking Alpha]Seeking Alpha
- MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- MaxCyte Inc (MXCT) Q4 2025 Earnings Call Highlights: Navigating Revenue Declines Amid Strategic ... [Yahoo! Finance]Yahoo! Finance
- MaxCyte (MXCT) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
MXCT
Earnings
- 3/24/26 - Miss
MXCT
Sec Filings
- 3/27/26 - Form 8-K
- 3/27/26 - Form SCHEDULE
- 3/25/26 - Form 10-K
- MXCT's page on the SEC website